Na
Natl Cancer Ctr Japan
GovTokyo JPFounded 19622,500 employees
Private CapacadPrivateOncology
Platform: Natl Cancer
Market Cap
N/A
All Drugs
2
Clinical Trials
2
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| NAT-IIT-209 | NAT-IIT-209 | Phase 2/3 | 1 | FLT3 | GIST | ||
| NAT-IIT-719 | NAT-IIT-719 | Preclinical | 1 | SHP2 | Obesity |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (1)